<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/css" href="/css/feed.css"?>
<rss xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" version="2.0">
<channel>
<title>The Anti-Doping Podcast</title>
<link>//podcastplus.net/feed/the-anti-doping-podcast~48d1f95a</link>
<description>Want to stay up to date on important issues in anti-doping research, technology, law, policy, and more? This podcast presented by the Partnership for Clean Competition covers important topics in the anti-doping field through interviews with experts including scientists, sport organizations, athletes, and other clean sport champions. The Partnership for Clean Competition is a global non-profit organization that is protecting the integrity of sport and public health by engaging and supporting the world’s top scientists and innovators in high-quality anti-doping research and development. The mission of this podcast is to increase awareness of issues related to anti-doping, educate the public about anti-doping science, policies, and practices, as well as to inspire people to pursue careers in anti-doping professions. The Anti-Doping Podcast is hosted by Marie McNeely, PhD.</description>
<pubDate>Mon, 05 Oct 2026 01:12:24 +0000</pubDate>
<item>
<title>159 - The 13-Year Battle for Olympic Bronze and the Impacts of Doping on Clean Athletes - Shannon Rowbury</title>
<link>https://traffic.libsyn.com/secure/antidoping/PCC_159_Shannon_Rowbury_Final_2.mp3?dest-id=1153835</link>
<description>  Shannon Rowbury is an accomplished elite U.S. track athlete and three-time Olympian. She is an Olympic bronze medalist, two-time World bronze medalist, World Record Holder in the distance medley relay, former American record holder in the 1,500 meter, 2 mile, and 5,000 meter races, and she has been ranked among the top ten female track athletes in the world for a decade. In addition, Shannon is a Managing Partner at West Strategy Group and co-founder and President of Imagining More, a non-profit organization that promotes arts and athletics for youth. She is also an Emmy-Award winning broadcaster, she’s been an in-stadium announcer, and Track &amp;amp; Field analyst. In this episode, Shannon discusses her career, her commitment to clean sport, and her experiences surrounding the 2012 Olympic Games in London. After crossing the finish line in sixth place in that race, Shannon has now officially been recognized as the bronze medalist after multiple competitors were disqualified for doping.   </description>
<pubDate>Tue, 07 Oct 2025 07:00:00 +0000</pubDate>
<guid>https://traffic.libsyn.com/secure/antidoping/PCC_159_Shannon_Rowbury_Final_2.mp3?dest-id=1153835</guid>
<enclosure url="https://traffic.libsyn.com/secure/antidoping/PCC_159_Shannon_Rowbury_Final_2.mp3?dest-id=1153835" type="audio/mpeg" length="1"/>
</item>
<item>
<title>126 - Studying the Experiences and Perspectives of Clean and Sanctioned Athletes - Cornelia Blank, PhD, and David Müller, PhD</title>
<link>https://traffic.libsyn.com/secure/antidoping/PCC_126_Cornelia_Blank_David_Muller.mp3?dest-id=1153835</link>
<description>  In this episode, Dr.   Cornelia   Blank and Dr. David Müller discuss a newly launched collaborative research project they are leading that is examining the experiences and perspectives of sanctioned athletes as well as clean athletes. The project is called Transforming Athletes’ Life Experiences after Doping into Education Resources and Policy Recommendations (TALE), and you can learn more at   https://athletes-tale.eu/  .   Cor  nelia is Professor and deputy head of the Institute for Sports Medicine, Alpine Medicine and Health Tourism at the University for Health Sciences and Health Tech in Hall in Tirol, Austria. David  is Head of Information and Education at the National Anti-Doping Agency Austria (NADA Austria). He is also head of the Medical Department and is the Quality Manager at NADA Austria.  </description>
<pubDate>Tue, 21 May 2024 07:00:00 +0000</pubDate>
<guid>https://traffic.libsyn.com/secure/antidoping/PCC_126_Cornelia_Blank_David_Muller.mp3?dest-id=1153835</guid>
<enclosure url="https://traffic.libsyn.com/secure/antidoping/PCC_126_Cornelia_Blank_David_Muller.mp3?dest-id=1153835" type="audio/mpeg" length="1"/>
</item>
<item>
<title>125 - Combatting Doping in Norwegian Sport and Among Youth in Norway - Anders Solheim</title>
<link>https://traffic.libsyn.com/secure/antidoping/PCC_125_Anders_Solheim_Final.mp3?dest-id=1153835</link>
<description>  Anders Solheim is CEO of Anti-Doping Norway, and he was recently elected as the Chair of the Board of the Institute of National Anti-Doping Organisations (iNADO). In this episode, Anders talks more about his career, his work as part of iNADO, landmark accomplishments for clean sport in Norway over the years, how the organization supports anti-doping research, current challenges in anti-doping, Anti-Doping Norway's goals for the future, and more.  </description>
<pubDate>Tue, 07 May 2024 07:00:00 +0000</pubDate>
<guid>https://traffic.libsyn.com/secure/antidoping/PCC_125_Anders_Solheim_Final.mp3?dest-id=1153835</guid>
<enclosure url="https://traffic.libsyn.com/secure/antidoping/PCC_125_Anders_Solheim_Final.mp3?dest-id=1153835" type="audio/mpeg" length="1"/>
</item>
<item>
<title>124 - Health and Clean Sport Risks of Supplements, Research Chemicals, and Biologics - Amy Eichner, PhD</title>
<link>https://traffic.libsyn.com/secure/antidoping/PCC_124_Amy_Eichner_Final.mp3?dest-id=1153835</link>
<description>  Dr. Amy Eichner is the Special Advisor on Drugs and Supplements at the U.S. Anti-Doping Agency (USADA). In this episode, she discusses risks and considerations for athletes who are thinking about taking dietary supplements, and work that USADA is doing to help reduce supplement-related risks for athletes. Dr. Eichner also covers research chemicals, some of the novel substances that are relevant in the context of clean sport, the anti-doping implications of the growing field of biologics, and more.  </description>
<pubDate>Tue, 16 Apr 2024 07:00:00 +0000</pubDate>
<guid>https://traffic.libsyn.com/secure/antidoping/PCC_124_Amy_Eichner_Final.mp3?dest-id=1153835</guid>
<enclosure url="https://traffic.libsyn.com/secure/antidoping/PCC_124_Amy_Eichner_Final.mp3?dest-id=1153835" type="audio/mpeg" length="1"/>
</item>
<item>
<title>123 - Leading Routine Work, Research, and Development in LA's Anti-Doping Lab - Brian Ahrens</title>
<link>https://traffic.libsyn.com/secure/antidoping/PCC_123_Brian_Ahrens_Final.mp3?dest-id=1153835</link>
<description>  Brian Ahrens is Director of the UCLA Olympic Analytical Laboratory in Los Angeles. In this episode Brian shares insights from more than three decades working in a WADA-accredited anti-doping laboratory, details on their daily operations, research and development efforts they are working on now, areas of opportunity in anti-doping research, and their preparations for the 2028 Olympic and Paralympic Games which will be held in Los Angeles.   </description>
<pubDate>Tue, 02 Apr 2024 07:00:00 +0000</pubDate>
<guid>https://traffic.libsyn.com/secure/antidoping/PCC_123_Brian_Ahrens_Final.mp3?dest-id=1153835</guid>
<enclosure url="https://traffic.libsyn.com/secure/antidoping/PCC_123_Brian_Ahrens_Final.mp3?dest-id=1153835" type="audio/mpeg" length="1"/>
</item>
<item>
<title>122 - Protecting Clean Sport and Public Health in Denmark - Kim Ravn</title>
<link>https://traffic.libsyn.com/secure/antidoping/PCC_122_Kim_Ravn_Final_V2.mp3?dest-id=1153835</link>
<description>  Kim Højgaard Ravn is Chief Executive Officer of Anti Doping Denmark, and he has worked for the organization for over ten years, serving in a variety of roles to advance clean sport. In our interview, Kim talks about his career, how the anti-doping landscape has evolved over the past decade, and the organization’s commitment to clean sport and supporting anti-doping science. Kim discusses the work they are doing at Anti-Doping Denmark currently, including anti-doping efforts in organized sports and also in gyms and fitness centers across the country.  </description>
<pubDate>Tue, 19 Mar 2024 07:00:00 +0000</pubDate>
<guid>https://traffic.libsyn.com/secure/antidoping/PCC_122_Kim_Ravn_Final_V2.mp3?dest-id=1153835</guid>
<enclosure url="https://traffic.libsyn.com/secure/antidoping/PCC_122_Kim_Ravn_Final_V2.mp3?dest-id=1153835" type="audio/mpeg" length="1"/>
</item>
<item>
<title>121 - Directing the Brazilian Doping Control Lab and Advancing Anti-Doping Research - Henrique Pereira, PhD</title>
<link>https://traffic.libsyn.com/secure/antidoping/PCC_121_Henrique_Pereira_Final.mp3?dest-id=1153835</link>
<description>   Dr.   Henrique   Marcelo Gualberto Pereira is Director of the Brazilian Doping Control Laboratory and Professor in the Department of Analytical Chemistry at the Federal University of Rio de Janeiro.   Henrique   is also President of the World Association of Anti-Doping Scientists (WAADS).   In our conversation, we talk about his background, the Brazilian Doping Control Laboratory, and the role of WAADS in the anti-doping community. He also shares some of the important research that he and his colleagues are working on, including using a   zebrafish water tank model to better understand the metabolism of prohibited substances and research aimed at better detecting use of cobalt, a prohibited substance that can impact red blood cell production.   </description>
<pubDate>Tue, 05 Mar 2024 08:00:00 +0000</pubDate>
<guid>https://traffic.libsyn.com/secure/antidoping/PCC_121_Henrique_Pereira_Final.mp3?dest-id=1153835</guid>
<enclosure url="https://traffic.libsyn.com/secure/antidoping/PCC_121_Henrique_Pereira_Final.mp3?dest-id=1153835" type="audio/mpeg" length="1"/>
</item>
<item>
<title>120 - The State of the Science Surrounding Blood Collection Devices from Tasso, Inc. - Matthew Fedoruk, PhD</title>
<link>https://traffic.libsyn.com/secure/antidoping/PCC_120_Matthew_Fedoruk.mp3?dest-id=1153835</link>
<description>  As a follow-up to our previous episode focused on innovative Blood Collection Devices from Tasso, Inc., Dr. Matthew   Fedoruk   joins us to discuss how Tasso's blood collection devices are being used in anti-doping and the state of the science of what we can detect with these devices for anti-doping purposes. He covers important benefits of these devices, current limitations, and some of the key milestones and future directions for implementation in anti-doping testing. Dr.   Fedoruk  is Chief Science Officer at the U.S. Anti-Doping Agency (USADA), and he is also Co-Chair of the Partnership for Clean Competition's Scientific Advisory Board.   </description>
<pubDate>Tue, 20 Feb 2024 08:00:00 +0000</pubDate>
<guid>https://traffic.libsyn.com/secure/antidoping/PCC_120_Matthew_Fedoruk.mp3?dest-id=1153835</guid>
<enclosure url="https://traffic.libsyn.com/secure/antidoping/PCC_120_Matthew_Fedoruk.mp3?dest-id=1153835" type="audio/mpeg" length="1"/>
</item>
<item>
<title>119 - How Tasso is Innovating Blood Collection in Anti-Doping and Beyond - RJ Asplund and Erwin Berthier, PhD</title>
<link>https://traffic.libsyn.com/secure/antidoping/PCC_119_Tasso_Final.mp3?dest-id=1153835</link>
<description>   Collecting blood samples is critical in anti-doping testing and a variety of clinical applications such as diagnostics and disease monitoring. However, traditional blood testing approaches can be a major pain point for athletes, sport organizations, patients, and their care teams.    Tasso, Inc. is a   company developing innovative products to improve the user experience surrounding blood collection. In this episode,   Dr. Erwin Berthier and RJ Asplund describe Tasso's current devices and how they work, the benefits of these products, and how their work is helping advance anti-doping.   Erwin is Co-Founder and Chief Technology Officer and RJ is Vice President of Commercial at Tasso, Inc.  </description>
<pubDate>Tue, 06 Feb 2024 08:00:00 +0000</pubDate>
<guid>https://traffic.libsyn.com/secure/antidoping/PCC_119_Tasso_Final.mp3?dest-id=1153835</guid>
<enclosure url="https://traffic.libsyn.com/secure/antidoping/PCC_119_Tasso_Final.mp3?dest-id=1153835" type="audio/mpeg" length="1"/>
</item>
<item>
<title>118 - Developing Novel Methods and Biomarkers to Detect Growth Hormone Doping  - Martin Bidlingmaier, MD</title>
<link>https://traffic.libsyn.com/secure/antidoping/PCC_118_Martin_Bidlingmaier_Final.mp3?dest-id=1153835</link>
<description>  Dr. Martin Bidlingmaier is Head of the Endocrine Laboratory, and he leads the Neuroendocrine Research Group in the Department of Internal Medicine at the Ludwig-Maximilians-University of Munich. Martin conducts clinical and basic research, particularly focusing on the development and validation of laboratory methods to diagnose and monitor pituitary and adrenal hormones, physiology, pathophysiology and biomarkers of growth hormone action, and endocrine aspects of doping in sports. In this episode, we discuss his work identifying new biomarkers and developing novel methods to measure growth hormone and detect growth hormone doping. He describes how growth hormone isoforms and the formation of complexes can help distinguish doping, and how the protein soluble α-klotho has emerged as a potential biomarker that may be useful in anti-doping analyses.  </description>
<pubDate>Tue, 16 Jan 2024 08:01:00 +0000</pubDate>
<guid>https://traffic.libsyn.com/secure/antidoping/PCC_118_Martin_Bidlingmaier_Final.mp3?dest-id=1153835</guid>
<enclosure url="https://traffic.libsyn.com/secure/antidoping/PCC_118_Martin_Bidlingmaier_Final.mp3?dest-id=1153835" type="audio/mpeg" length="1"/>
</item>
</channel>
</rss>
